ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?
This week we’re talking about a new company called Positive Development, which offers developmental therapies paid for by insurance, currently in Florida, New Jersey, California, and coming soon to Illinois. Maryanne Nugent is the Chief Operating Officer and the parent of a 23-year-old son who received DIR/Floortime when he was 3. Returning guest, Dr. Joshua Feder, is the Medical Director, an Expert Training Leader in the Developmental, Individual differences, Relationship-based (DIR) Model and a child and family psychiatrist, among other things as we know from our past podcasts.
https://affectautism.com/2021/07/31/positive-development/
You Might Also Enjoy...
ADHD is one of the most treatable conditions in psychiatry if patients adhere to medication regimens. So, why are parents so resistant to stimulant medications and how can we approach these misconceptions?
Each year in the US, there are about 1.04 million divorces, affecting about 800,000 children. How can we navigate the complexities of treating a child with divorce?
Do antipsychotics have neurotoxic effects in youth? In this episode, we’ll be banging the drum of caution about antipsychotic use in children and adolescents.
With a growing body of evidence supporting its clinical efficacy and cost-effectiveness relative to traditional ABA approaches, the developmental model is being used with increasing prevalence across the US.
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As leaders we want to be kind while being effective, and this can be difficult. How do make sure that we do not become tired and angry but instead stay fresh and creative? Hear Zoe Kernohan Neely, Josh Feder MD & Jerri Lynn Hogg PhD in three mini videos.